Fundraising Fox

Blue Cell Therapeutics

Founded 2019 · 16 employees on LinkedIn · 1 known investors

Blue Cell Therapeutics develops an off-the-shelf allogeneic stem cell therapy platform (Blue Cells) that promotes angiogenesis and nerve repair, with a lead candidate (BlueC-231) aimed at treating severe erectile dysfunction in men after radical prostatectomy. The company operates in the biotech and cell therapy space, targeting patients unresponsive to existing drug treatments.

BiotechDigital HealthMedical Devices

Founders & leadership

Blue Cell Therapeutics was founded in 2019 by Søren P Sheikh.

SP
Søren P SheikhinFounder

Investors · 1

Seier CapitalSt Gallenvia Lars Seier Christensen · inferred

In the news

Blue Cell Therapeutics appoints highly experienced pharma and biotech executive Olav Hellebø as Chairman of the Board of Directorsfinance.yahoo.com · Sep 2025Blue Cell Therapeutics x Innovayt // Eurostars and Innobooster - Innovaytinnovayt.eu · Aug 2022BLUE CELL THERAPEUTICS: Protect your good ideas in timepv.eu · Jan 2021

Frequently asked questions

What does Blue Cell Therapeutics do?
Blue Cell Therapeutics develops an off-the-shelf allogeneic stem cell therapy platform (Blue Cells) that promotes angiogenesis and nerve repair, with a lead candidate (BlueC-231) aimed at treating severe erectile dysfunction in men after radical prostatectomy. The company operates in the biotech and cell therapy space, targeting patients unresponsive to existing drug treatments.
Who founded Blue Cell Therapeutics?
Blue Cell Therapeutics was founded by Søren P Sheikh in 2019.
Who are Blue Cell Therapeutics's investors?
Blue Cell Therapeutics's investors include Seier Capital.